Poster 404 Randomized, Double-Blind Placebo-Controlled Phase III Study of Dysport®, AbobotulinumtoxinA, in the Treatment of Adults with Upper Limb Spasticity

Jean-Michel Gracies; Allison Brashear; Peter Mc Allister; Heather W. Walker; Christina M. Marciniak; Fatma Gul; Steven R. Edgley; Philippe Picaut; Doctor of Pharmacy

doi:10.1016/j.pmrj.2014.08.779

Poster 404 Randomized, Double-Blind Placebo-Controlled Phase III Study of Dysport®, AbobotulinumtoxinA, in the Treatment of Adults with Upper Limb Spasticity

PM&R ◽

10.1016/j.pmrj.2014.08.779 ◽

2014 ◽

Vol 6 (9) ◽

pp. S327

Author(s):

Jean-Michel Gracies ◽

Allison Brashear ◽

Peter Mc Allister ◽

Heather W. Walker ◽

Christina M. Marciniak ◽

...

Keyword(s):

Upper Limb ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Limb Spasticity

Download Full-text

No. 17 Efficacy and Safety of AbobotulinumtoxinA (Dysport®) in the Treatment of Adults With Upper Limb Spasticity: Randomized Double-Blind Placebo-Controlled Phase III Study

PM&R ◽

10.1016/j.pmrj.2014.08.355 ◽

2014 ◽

Vol 6 (8) ◽

pp. S85

Author(s):

Jean Michel Gracies ◽

Allison Brashear ◽

Robert Jech ◽

Philippe Picaut

Keyword(s):

Upper Limb ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Limb Spasticity

Download Full-text

Initial results from the international double-blind phase III study of Dysport® in the treatment of adults with upper limb spasticity

Annals of Physical and Rehabilitation Medicine ◽

10.1016/j.rehab.2014.03.156 ◽

2014 ◽

Vol 57 ◽

pp. e43-e44

Author(s):

J.M. Gracies ◽

R. Jech ◽

M. Banach ◽

P. Valkovic ◽

A. Brashear ◽

...

Keyword(s):

Upper Limb ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Study ◽

Limb Spasticity ◽

Initial Results

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty Opinions recommendation of Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962498.793465528 ◽

2012 ◽

Author(s):

David Alpers

Keyword(s):

Peritoneal Carcinomatosis ◽

Bowel Obstruction ◽

Symptomatic Treatment ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

PIII-38Long-term effects of ramelteon on endocrine function in patients with chronic insomnia in a double-blind, placebo-controlled phase III study

Clinical Pharmacology & Therapeutics ◽

10.1016/j.clpt.2005.12.246 ◽

2006 ◽

Vol 79 (2) ◽

pp. P68-P68 ◽

Cited By ~ 5

Author(s):

G RICHARDSON ◽

S WANGWEIGAND ◽

S SAINATI ◽

S DEMISSIE

Keyword(s):

Endocrine Function ◽

Phase Iii ◽

Chronic Insomnia ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain

Journal of Pain ◽

10.1016/j.jpain.2009.01.202 ◽

2009 ◽

Vol 10 (4) ◽

pp. S48 ◽

Cited By ~ 5

Author(s):

R. Buynak ◽

D. Shapiro ◽

A. Okamoto ◽

C. Lange ◽

M. Etropolski

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Phase Iii ◽

Low Back ◽

Double Blind ◽

Double Blind Placebo ◽

Gastrointestinal Tolerability ◽

Phase Iii Study

Download Full-text

J-FORCE study: A randomized, double-blind, placebo-controlled phase III study evaluating olanzapine (5 mg) combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based, highly emetogenic chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdx388.064 ◽

2017 ◽

Vol 28 ◽

pp. v564-v565

Author(s):

H. Hashimoto ◽

S. Iwasa ◽

M. Abe ◽

T. Yanai ◽

S. Zenda ◽

...

Keyword(s):

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Antiemetic Therapy ◽

Phase Iii ◽

Highly Emetogenic Chemotherapy ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2‐Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double‐Blind, Placebo‐Controlled Phase III Study

The Oncologist ◽

10.1634/theoncologist.2012-0448 ◽

2013 ◽

Vol 18 (3) ◽

pp. 257-264 ◽

Cited By ~ 86

Author(s):

Sandra M. Swain ◽

Michael S. Ewer ◽

Javier Cortés ◽

Dino Amadori ◽

David Miles ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Her2 Positive ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke

Stroke ◽

10.1161/01.str.31.10.2402 ◽

2000 ◽

Vol 31 (10) ◽

pp. 2402-2406 ◽

Cited By ~ 190

Author(s):

A. M. O. Bakheit ◽

A. F. Thilmann ◽

A. B. Ward ◽

W. Poewe ◽

J. Wissel ◽

...

Keyword(s):

Botulinum Toxin ◽

Upper Limb ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Limb Spasticity ◽

Dose Ranging

Download Full-text